![]() |
시장보고서
상품코드
1619218
동물용 백신 시장 규모, 점유율, 성장 분석 : 제품별, 투여 경로별, 지역별 - 산업별 예측(2024-2031년)Animal Vaccines Market Size, Share, Growth Analysis, By Product (Attenuated Live Vaccines, Inactivated Vaccines), By Route of Administration (Subcutaneous, Intramuscular), By Region - Industry Forecast 2024-2031 |
세계의 동물용 백신 시장 규모는 2022년에 124억 달러로 평가되며, 2023년 135억 9,000만 달러에서 2031년에는 283억 달러로 성장하며, 예측 기간 중(2024-2031년) CAGR은 9.60%로 성장할 전망입니다.
가축 인구의 증가와 함께 동물 질병의 발생률이 상승하고 있으며, 이는 반추동물 백신, 특히 소용 백신의 세계 보급을 크게 촉진하고 있습니다. 가축은 육류, 우유, 양모, 가죽 생산에 필수적이기 때문에 광견병, 말 인플루엔자, 구제역 등 가축의 건강과 생산성을 저해하는 질병을 예방하기 위한 백신 접종이 시급한 실정입니다. 식량안보에 대한 우려가 커지고 축산업이 급증하면서 백신에 대한 수요가 더욱 증가하고 있습니다. 인구 증가와 함께 소비자의 기호가 진화하면서 축산물에 대한 욕구도 증가하고 있습니다. 또한 백신 기술의 발전과 빈번한 질병 발생은 시장 역학을 재구성하여 가축 백신 분야의 지속적인 확장에 기여하고 있습니다.
Global Animal Vaccines Market size was valued at USD 12.4 billion in 2022 and is poised to grow from USD 13.59 billion in 2023 to USD 28.30 billion by 2031, growing at a CAGR of 9.60% during the forecast period (2024-2031).
The rising incidence of animal diseases, coupled with a growing livestock population, is significantly boosting the global acceptance of ruminant vaccines, especially for cattle. With animals being vital for producing meat, milk, wool, and leather, there is an increased urgency for vaccination to prevent diseases like rabies, equine influenza, and foot-and-mouth disease that compromise animal health and productivity. The escalating concerns surrounding food security and the surge in animal husbandry practices are further driving demand for these vaccines. As consumer preferences evolve alongside population growth, the appetite for livestock products intensifies. Moreover, advancements in vaccine technology and frequent disease outbreaks are reshaping market dynamics, contributing to continued expansion in the livestock vaccination sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Animal Vaccines Market Segmental Analysis
Global Animal Vaccines Market is segmented by Product, Route of Administration, Animal Type, Distribution Channel, and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Subcutaneous, Intramuscular, and Intranasal. Based on Animal Type, the market is segmented into Livestock, and Companion Based on Distribution Channel, the market is segmented into Retail, E-Commerce, and Hospital/ Clinic Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Animal Vaccines Market
The Global Animal Vaccines market is significantly driven by the rising incidence of zoonotic diseases, which have a detrimental impact on human health and underscore the urgent need for effective animal immunization. The escalating threat posed by emerging and exotic diseases compromises not only human and animal well-being but also jeopardizes food security. With increasing human and animal populations, coupled with environmental changes and the globalization of trade and travel, there are heightened risks for pathogen transmission across species. Furthermore, advancements in technology have transformed animal vaccination practices, leading to substantial R&D breakthroughs. Traditional vaccination methods have paved the way for the development of recombinant vaccines, which offer enhanced safety benefits by eliminating exposure to live pathogens. These dynamics collectively drive the demand for innovative animal vaccines in today's market.
Restraints in the Global Animal Vaccines Market
The Global Animal Vaccines market faces significant constraints, particularly in developing regions such as Africa, Asia, and Latin America, where an estimated 600-900 million smallholder farmers manage livestock. The adoption of animal vaccinations among these farmers is hindered by multiple challenges, including a lack of awareness regarding the advantages of vaccination, financial limitations that prevent access to immunization products, and the inadequate supply chain that restricts availability. As a result, many livestock animals owned by smallholder farmers succumb to various diseases, leading to further economic hardships for these communities. Governments and organizations are implementing strategies to enhance the accessibility, availability, and affordability of animal vaccination to improve livestock health in these areas.
Market Trends of the Global Animal Vaccines Market
The Global Animal Vaccines market is poised for substantial growth, driven by a surge in public-private funding for targeted research initiatives and a heightened prevalence of animal diseases. Technological advancements are facilitating product innovations, presenting lucrative opportunities for market players. Future growth will be further supported by increasing strategic alliances, enhanced internet penetration, and heightened concerns regarding zoonotic diseases. Additionally, advancements in diagnostics and therapeutics in developing regions, coupled with rising per capita healthcare spending, will amplify market demand. Collectively, these factors are positioning the animal vaccines sector as a critical market trend in the evolving landscape of veterinary healthcare.